Emma Aneheim

Goeteborg, O SE41345, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Solving the limited availability of Astatine-211 from a European perspective: from production to the end user.

Solving the limited availability of Astatine-211 from a European perspective: from production to the end user.

Journal: EJNMMI radiopharmacy and chemistry

Published: November 24, 2025

Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin.

Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin.

Journal: Nuclear medicine and biology

Published: September 12, 2025

Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.

Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.

Journal: EJNMMI research

Published: July 08, 2025

An 211At-labeled Tetrazine for Pretargeted Therapy.

An 211At-labeled Tetrazine for Pretargeted Therapy.

Journal: Journal of medicinal chemistry

Published: February 18, 2025

Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy.

Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 09, 2024

Radiolabeling yield dependency of post-dry distillation decay of astatine-211.

Radiolabeling yield dependency of post-dry distillation decay of astatine-211.

Journal: Nuclear medicine and biology

Published: August 26, 2024

Rapid Electrophilic 211At-Astatination of Trimethylgermyl Arenes.

Rapid Electrophilic 211At-Astatination of Trimethylgermyl Arenes.

Journal: ChemPlusChem

Published: April 07, 2024

In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.

In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 25, 2024

A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro.

A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: January 24, 2024

Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.

Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 15, 2023

Behaviour, use and safety aspects of astatine-211 solvated in chloroform after dry distillation recovery.

Behaviour, use and safety aspects of astatine-211 solvated in chloroform after dry distillation recovery.

Journal: Scientific reports

Published: October 16, 2023

A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial.

A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial.

Journal: PloS one

Published: October 16, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026